Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Western Blotting01:15

Western Blotting

14.3K
Western blotting is an analytical technique for protein identification. It has various applications in immunology and medicine, including detecting diseases like bovine spongiform encephalopathy, mad cow disease, and human and feline immunodeficiency virus from biological samples.
The technique begins with separating proteins from the sample using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by protein transfer, immunoblotting, and finally, protein detection.
14.3K
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

14.1K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine.

Journal of clinical medicine·2026
Same author

Changes in Plasma Amyloid β 1-42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer's Disease Using an Immunomagnetic Reduction Assay.

ACS omega·2026
Same author

Hydrolyzed chicken extract (ProBeptigen®) on sleep quality in healthy individuals: a secondary analysis of PSQI global and component scores from a randomized double-blind trial.

Frontiers in nutrition·2026
Same author

Reply to commentary on "Cogstate brief battery performance in assessing cognitive impairment in Taiwan: A prospective, multi-center study".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Digital reminiscence therapy in dementia care: a systematic review and meta-analysis.

BMC neurology·2026
Same author

Chronic cerebral hypoperfusion exacerbates amyloid and tau pathology by impairing glymphatic transport via AQP4- and VEGF-mediated pathways: insights from a vascular to mixed-type dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: May 1, 2026

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval
10:48

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval

Published on: April 23, 2010

24.0K

Ultrasensitive Assays Detect Different Conformations of Plasma β Amyloids.

Chia-Yu Li1, Ling-Yun Fan2, Chin-Hsien Lin1,3,4

  • 1Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 100, Taiwan.

ACS Omega
|March 3, 2025
PubMed
Summary

The immunomagnetic reduction (IMR) assay detects both amyloid-beta 1-42 (Aβ1-42) monomers and oligomers, unlike the SIMOA assay which primarily measures monomers. This difference explains inconsistencies in Alzheimer's disease (AD) plasma Aβ1-42 measurements.

More Related Videos

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
06:34

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

11.8K
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.8K

Related Experiment Videos

Last Updated: May 1, 2026

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval
10:48

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval

Published on: April 23, 2010

24.0K
A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
06:34

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

11.8K
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.8K

Area of Science:

  • Biochemistry
  • Neuroscience
  • Biotechnology

Background:

  • Ultrasensitive assays like immunomagnetic reduction (IMR) and single molecule array (SIMOA) enable blood-based amyloid-beta 1-42 (Aβ1-42) detection.
  • Inconsistent plasma Aβ1-42 measurements in Alzheimer's disease (AD) versus cognitively unimpaired (CU) subjects may stem from varying Aβ1-42 conformations.

Purpose of the Study:

  • To investigate the impact of Aβ1-42 conformation (monomers vs. oligomers) on plasma concentration measurements.
  • To compare the performance of IMR and SIMOA assays in detecting different Aβ1-42 forms.

Main Methods:

  • Preparation of three samples with equal total Aβ1-42 but varying monomer/oligomer ratios.
  • Analysis of Aβ1-42 composition using Western blot.
  • Assay of samples using IMR and SIMOA for Aβ1-42 quantification.

Main Results:

  • IMR assay yielded similar Aβ1-42 levels across samples regardless of monomer/oligomer proportion.
  • SIMOA assay showed lower Aβ1-42 levels in samples with higher oligomer content, indicating it primarily measures monomers.
  • Observed discrepancies in plasma Aβ1-42 levels between AD and CU subjects using IMR are attributed to oligomeric Aβ1-42 formation.

Conclusions:

  • IMR assay is suitable for detecting total Aβ1-42 (monomers and oligomers), while SIMOA is optimal for measuring monomers only.
  • The choice of assay depends on whether total Aβ1-42 or specifically monomeric forms are the target.
  • Further research is needed to elucidate the clinical significance of oligomeric Aβ1-42 proportions in AD.